Physician profile
Raseefa Anwar
NPI 1316220130
$1,592.84
in general payments reported to CMS, 2019-2025
18 companies · $233 in 2025
The $233 reported for 2025 was more than what 78% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $44.60 · 2021: $103 · 2022: $271 · 2023: $324 · 2024: $409 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $457.66 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $227.65 | 2022-2024 | Jornay Pm |
| Kaleo, INC. | $175.95 | 2019-2022 | |
| Pfizer INC. | $107.63 | 2019-2023 | |
| Sanofi Pasteur INC. | $101.95 | 2019-2025 | |
| Neos Therapeutics, LP | $78.11 | 2019-2025 | Adzenys Xr-Odt, Cotempla Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $74.15 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $64.77 | 2022-2025 | Gardasil 9, Vaxelis, Gardasil |
| Boston Scientific Corporation | $52.58 | 2023 | Varithena Administration Pack |
| Sanofi-Aventis U.S. LLC | $43.01 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $41.40 | 2025 | Jornay Pm |
| Tris Pharma INC | $38.51 | 2024 | Dyanavel Xr |
| Cranial Technologies, INC | $35.01 | 2022-2024 | Doc Band |
| Ars Pharmaceuticals Operations, INC. | $24.39 | 2025 | Neffy |
| Biomerieux INC | $23.82 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $17.32 | 2024 | Bexsero |
| Sobi, INC | $16.45 | 2023 | |
| Adlon Therapeutics L.P. | $12.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raseefa Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.